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*Serratia marcescens* is a Gram-negative bacillus belonging to the family *Enterobacteriaceae*. This opportunistic organism has been responsible for nosocomial infections of the respiratory tract, urinary tract, and bloodstream ([@B1], [@B2]). In addition, outbreaks of β-lactamase-producing *S. marcescens* in hospital settings have been frequently reported, making chemotherapy against *S. marcescens* infection difficult ([@B3][@B4][@B5]). Phage therapy presents a possible approach to controlling infections caused by multidrug-resistant *S. marcescens*.

Bacteriophage SM9-3Y was isolated from raw sewage collected from the First Affiliated Hospital of Jilin University, and it formed clear plaques. Bacteriophage SM9-3Y was propagated on 8 out of 25 tested clinical strains. The morphology of phage particles was measured using transmission electron microscopy. SM9-3Y showed a 48 ± 0.4-nm icosahedral capsid with a short tail and was assigned to the family *Podoviridae*. Phage DNA was sequenced at Suzhou Genewiz Biological Technology Co., Ltd. (Suzhou, China), using an Illumina MiSeq 250-bp paired-end run with a 546-bp insert library. A total of 3,095,936 reads (928,780,800 bp) were trimmed and assembled using SSPACE and GapFiller (BaseClear). Open reading frame (ORF) prediction and annotation were performed using Glimmer version 3.02 ([@B6]) and protein BLAST ([@B7]) and were subsequently confirmed using the Rapid Annotation using Subsystem Technology (RAST) server ([@B8]). tRNAscan-SE was employed to predict the presence of tRNA genes ([@B9]), but no putative genes coding for tRNAs were discovered in phage SM9-3Y.

The genome of phage SM9-3Y consists of 39,631 bp of linear double-stranded DNA (dsDNA) flanked by terminal repeats of 300 bp, with a G+C content of 50.7%. The genome of phage SM9-3Y shares high nucleotide identity (96%) with *Serratia* phage 2050H2. Of the 48 ORFs predicted, 17 encoded hypothetical proteins. The remaining 31 ORFs were categorized into 5 functional groups, that is, DNA metabolism (exonuclease, DNA-directed RNA polymerase, DNA ligase, endonuclease, DNA primase/helicase, and DNA polymerase), phage structure (head-to-tail joining protein, capsid and scaffold protein, minor capsid protein, tail tubular proteins, internal virion proteins, and tail fiber protein), packaging (DNA-packaging protein A, DNA-packaging protein B, and HNH endonuclease), lytic features (*N*-acetylmuramoyl-[l]{.smallcaps}-alanine amidase, holin, i-spanin, and o-spanin), and additional functions (*S*-adenosyl-[l]{.smallcaps}-methionine hydrolase, protein kinase, dGTP triphosphohydrolase inhibitor, bacterial RNA polymerase inhibitor, and HNS binding protein).
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The genome sequence of phage SM9-3Y has been deposited in GenBank under the accession number [KX778611](http://www.ncbi.nlm.nih.gov/nuccore/KX778611). The version described here is KX778611.3.
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